127
Views
2
CrossRef citations to date
0
Altmetric
Original Research

SOX10 Knockdown Inhibits Melanoma Cell Proliferation via Notch Signaling Pathway

&
Pages 7225-7234 | Published online: 17 Sep 2021

References

  • WickleinD, OttoB, SulingA, et al. Ceacam1 promotes melanoma metastasis and is involved in the regulation of the emt associated gene network in melanoma cells. Sci Rep. 2018;8(1):11893. doi:10.1038/s41598-018-30338-430089785
  • GrzywaTM, PaskalW, WłodarskiPK. Intratumor and intertumor heterogeneity in melanoma. Transl Oncol. 2017;10(6):956–975. doi:10.1016/j.tranon.2017.09.00729078205
  • HarrisML, BaxterLL, LoftusSK, et al. Sox proteins in melanocyte development and melanoma. Pigment Cell Melanoma Res. 2010;23(4):496–513. doi:10.1111/j.1755-148X.2010.00711.x20444197
  • HerbarthB, PingaultV, BondurandN, et al. Mutation of the sry-related sox10 gene in dominant megacolon, a mouse model for human Hirschsprung disease. Proc Natl Acad Sci U S A. 1998;95(9):5161–5165. doi:10.1073/pnas.95.9.51619560246
  • YuL, PengF, DongX, et al. Sex-determining region y chromosome-related high-mobility-group box 10 in cancer: a potential therapeutic target. Front Cell Dev Biol. 2020;8:564740. doi:10.3389/fcell.2020.56474033344444
  • MurisierF, GuichardS, BeermannF. The tyrosinase enhancer is activated by sox10 and mitf in mouse melanocytes. Pigment Cell Res. 2007;20(3):173–184. doi:10.1111/j.1600-0749.2007.00368.x17516925
  • GlatzK. [molecular heterogeneity of malignant melanomas]. Pathologe. 2007;28(6):474–478. German. doi:10.1007/s00292-007-0942-617885757
  • ShakhovaO, ZinggD, SchaeferSM, et al. Sox10 promotes the formation and maintenance of giant congenital naevi and melanoma. Nat Cell Biol. 2012;14(8):882–890. doi:10.1038/ncb253522772081
  • CroninJC, Watkins-ChowDE, IncaoA, et al. Sox10 ablation arrests cell cycle, induces senescence, and suppresses melanomagenesis. Cancer Res. 2013;73(18):5709–5718. doi:10.1158/0008-5472.CAN-12-462023913827
  • GrafSA, BuschC, BosserhoffAK, et al. Sox10 promotes melanoma cell invasion by regulating melanoma inhibitory activity. J Invest Dermatol. 2014;134(8):2212–2220. doi:10.1038/jid.2014.12824608986
  • GrafSA, HepptMV, WesselyA, et al. The myelin protein pmp2 is regulated by sox10 and drives melanoma cell invasion. Pigment Cell Melanoma Res. 2019;32(3):424–434. doi:10.1111/pcmr.1276030506895
  • Huang daW, ShermanBT, LempickiRA. Systematic and integrative analysis of large gene lists using david bioinformatics resources. Nat Protoc. 2009;4(1):44–57. doi:10.1038/nprot.2008.21119131956
  • TomczakK, CzerwinskaP, WiznerowiczM. The cancer genome atlas (TCGA): an immeasurable source of knowledge. Contemp Oncol (Pozn). 2015;19(1A):A68–A77.25691825
  • TangZ, LiC, KangB, et al. Gepia: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–W102. doi:10.1093/nar/gkx24728407145
  • OrmöM, CubittAB, KallioK, et al. Crystal structure of the aequorea victoria green fluorescent protein. Science. 1996;273(5280):1392–1395. doi:10.1126/science.273.5280.13928703075
  • UhlénM, FagerbergL, HallströmBM, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015;347(6220):1260419. doi:10.1126/science.126041925613900
  • LuoX, XiongX, ShaoQ, et al. The tumor suppressor interferon regulatory factor 8 inhibits β-catenin signaling in breast cancers, but is frequently silenced by promoter methylation. Oncotarget. 2017;8(30):48875–48888. doi:10.18632/oncotarget.1651128388578
  • UkaR, BritschgiC, KrättliA, et al. Temporal activation of wnt/β-catenin signaling is sufficient to inhibit sox10 expression and block melanoma growth. Oncogene. 2020;39(20):4132–4154. doi:10.1038/s41388-020-1267-732238882
  • WillisBC, JohnsonG, WangJ, et al. Sox10: a useful marker for identifying metastatic melanoma in sentinel lymph nodes. Appl Immunohistochem Mol Morphol. 2015;23(2):109–112. doi:10.1097/PAI.000000000000009725356946
  • MohamedA, GonzalezRS, LawsonD, et al. Sox10 expression in malignant melanoma, carcinoma, and normal tissues. Appl Immunohistochem Mol Morphol. 2013;21(6):506–510. doi:10.1097/PAI.0b013e318279bc0a23197006
  • Ramos-HerberthFI, KaramchandaniJ, KimJ, et al. Sox10 immunostaining distinguishes desmoplastic melanoma from excision scar. J Cutan Pathol. 2010;37(9):944–952. doi:10.1111/j.1600-0560.2010.01568.x20653825
  • LoftusSK. Decreased melanoma proliferation and cell survival: turn down your sox10. Pigment Cell Melanoma Res. 2013;26(1):3–4. doi:10.1111/pcmr.1202823387001
  • AyyildizD, PiazzaS. Introduction to bioinformatics. Methods Mol Biol. 2019;1986:1–15.31115882
  • OrdóñezNG. Value of sox10 immunostaining in tumor diagnosis. Adv Anat Pathol. 2013;20(4):275–283. doi:10.1097/PAP.0b013e318297a9d023752089
  • KontomanolisEN, KalagasidouS, PouliliouS, et al. The notch pathway in breast cancer progression. Scientific World J. 2018;2018:2415489. doi:10.1155/2018/2415489
  • PorcelliL, MazzottaA, GarofoliM, et al. Active notch protects MAPK activated melanoma cell lines from mek inhibitor cobimetinib. Biomed Pharmacother. 2021;133:111006. doi:10.1016/j.biopha.2020.11100633202284
  • MüllerCS. Notch signaling and malignant melanoma. Adv Exp Med Biol. 2012;727:258–264.22399353
  • HowardJD, MoriartyWF, ParkJ, et al. Notch signaling mediates melanoma-endothelial cell communication and melanoma cell migration. Pigment Cell Melanoma Res. 2013;26(5):697–707. doi:10.1111/pcmr.1213123773728
  • KaushikG, VenugopalA, RamamoorthyP, et al. Honokiol inhibits melanoma stem cells by targeting notch signaling. Mol Carcinog. 2015;54(12):1710–1721. doi:10.1002/mc.2224225491779
  • YinH, QinC, ZhaoY, et al. Sox10 is over-expressed in bladder cancer and contributes to the malignant bladder cancer cell behaviors. Clin Transl Oncol. 2017;19(8):1035–1044. doi:10.1007/s12094-017-1641-228258492
  • JamidiSK, HuJ, AphivatanasiriC, et al. Sry-related high-mobility-group/hmg box 10 (sox10) as a sensitive marker for triple-negative breast cancer. Histopathology. 2020;77(6):936–948. doi:10.1111/his.1411832304249
  • BrauneEB, LendahlU. Notch – a goldilocks signaling pathway in disease and cancer therapy. Discov Med. 2016;21(115):189–196.27115169